Lipid Insights Podcast

Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they will explore the integration of Lp(a) assessment into routine practice, implications for high-risk populations including those with familial hypercholesterolemia (FH), and strategies to mitigate cardiovascular risk until targeted therapies become available.

Watch the video episode on YouTube HERE

Podcast Listeners can claim credit for this program by clicking here

Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science.

Watch the video episode on YouTube HERE

Read the abstract HERE.

In this episode of Lipid Insights, Dr. Peter Jones and guest Dr. Kevin Maki explore whether beef deserves its long-standing reputation as a driver of cardiovascular disease. Drawing on a recent systematic review and meta-analysis, they examine beef’s impact on cholesterol, blood pressure, and other key CVD risk factors—providing fresh perspective for clinicians navigating dietary guidance.

Podcast Listeners can claim credit for this program by clicking here

In this episode of Lipid Insights, Dr. Daniel Soffer interviews the Young Investigator abstract award winner during the 2025 Annual Scientific Sessions in Miami, Florida. Dr. Joshua Hyman is a resident at Yale and is also an NLA lipid scholarship program recipient. His abstract, "Universal lipoprotein(a) screening of youth and reverse cascade screening at a primary care clinic" focuses on a study that demonstrates the feasibility of universal Lp(a) screening of youth and reverse cascade screening in a primary care setting.

Watch the video episode on YouTube HERE

Hosted by Dr. Dan Soffer, this conversation brings NLA President Dr. Willard and Beth Jackson together to unpack the Association's guidance, “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better”. The trio turns a big message into practical moves: why lifetime LDL exposure matters, who needs more aggressive targets, and how to streamline therapy choices from high-intensity statins to add-ons (ezetimibe, PCSK9-directed options) when goals aren’t met. They share real-world tactics on adherence, stepwise intensification, shared decision-making, and navigating special populations—all in a clear, clinic-ready format.

Watch the video episode on YouTube HERE

Read the JCL Article HERE

In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic approach safely and effectively reduces plasma triglycerides and remnant cholesterol—key drivers of residual cardiovascular risk. Listeners will gain insight into the mechanism of action, clinical significance, and potential role of ANGPTL4 inhibition in the evolving landscape of lipid management.

Watch the video episode on YouTube HERE.

Explore the NLA’s new guidance on building effective, team-based approaches to improve outcomes in clinical lipidology and cardiometabolic care.

Watch the video episode on YouTube HERE

Read the Expert Clinical Review HERE

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne, MD, is joined by leading experts Seyedmohammad Saadatagah, MD, Erin Michos, MD, and Daniel Gaudet, MD, PhD, to break down key takeaways from the newly released Joint Expert Clinical Consensus from the National Lipid Association and the American Society for Preventive Cardiology: Recognition and Management of Persistent Chylomicronemia. This engaging discussion explores diagnostic challenges, treatment strategies, and why recognizing this condition is critical to preventing severe complications like pancreatitis. Don’t miss this deep dive into one of the most misunderstood lipid disorders.

Watch the video episode on YouTube HERE

Read the Clinical Consensus Open-Access HERE

Listen to Dr. Alan Brown discuss the latest FCS paper with Dr. Fiza Javed and Dr. Nivedita Patni.

Listen to the latest podcast with Anna Biggins MPH, RDN, LD and Lauren Williams MCN, RDN, LD discussing recent fad diets and supplements.

Listen to Dr. Jones speak with Shannon Christen about FCS research and therapies and recent developments.

Listen to Dr. Jones discuss the topic of nutrition-related clinical trials with Dr. Kris-Etherton and Dr. Petersen from the recent JCL publication.

Additional Materials: Journal Article

Listen to Dr. Brown discuss with Dr. Saseen the Scientific Statement from the NLA and the AGS on managing hypercholesterolemia in adults aged 57 and older who do not have a history of ASCVD.

Listen to Dr. Brown discuss with Dr. Saseen and Dr. Maki about the role of apolipoprotein B in the clinical management of cardiovascular risk in adults.

Additional Materials: Journal Article

Listen to Dr. Brown discuss with Dr. Koschinsky and Dr. Pena about how this important lipoprotein and potent cardiovascular risk marker is transitioning from the purview of the specialist to that of the general practitioner. Its clinical adoption as an important test is increasing in momentum.

Additional Materials: Journal Article

Alan Brown, MD, MHA, MNLA talks with Robert A. Hegele MD, FRCP about the Palisade Phase 3 Data

Alan Brown, MD, MHA, MNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"